Literature DB >> 1605579

Cytotoxic conjugates containing translational inhibitory proteins.

S Ramakrishnan1, D Fryxell, D Mohanraj, M Olson, B Y Li.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1605579     DOI： 10.1146/annurev.pa.32.040192.003051

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN： 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  5 in total

1.  Purification, characterization and molecular cloning of trichoanguin, a novel type I ribosome-inactivating protein from the seeds of Trichosanthes anguina.

Authors:  L P Chow; M H Chou; C Y Ho; C C Chuang; F M Pan; S H Wu; J Y Lin
Journal:  Biochem J       Date:  1999-02-15       Impact factor: 3.857

Review 2.  Designing immunotoxins for cancer therapy.

Authors:  Christopher A Pennell; Heidi A Erickson
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

3.  Comparative studies on kinetics of inhibition of protein synthesis in intact cells by ricin and a conjugate of ricin B-chain with momordin.

Authors:  S Sharma; S K Podder; A A Karande
Journal:  Mol Cell Biochem       Date:  1999-10       Impact factor: 3.396

4.  Anti-CD30 immunotoxins with native and recombinant dianthin 30.

Authors:  A Bolognesi; P L Tazzari; G Legname; F Olivieri; D Modena; R Conte; F Stirpe
Journal:  Cancer Immunol Immunother       Date:  1995-02       Impact factor: 6.968

5.  Inhibition of angiogenesis and tumour growth by VEGF121-toxin conjugate: differential effect on proliferating endothelial cells.

Authors:  R Wild; M Dhanabal; T A Olson; S Ramakrishnan
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.